• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAffimed NV
    Picture of Affimed NV logo

    AFMDQ — Affimed NV Share News

    $0.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $0.00m
    • Enterprise Value
      -$12.57m
    • Revenue
      €8.28m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • AFMDQ Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    AFMDQ Dividends
    • Brief: Affimed presents data on potency of NK- and T-cell EGFRvIII tandabs

      06/11/2015 10:02
    • Brief: Affimed says existing shareholder increased position in Co by buying 3.3 million shares

      14/10/2015 21:00
    • Brief: Affimed files for mixed shelf of up to $150 mln

      01/10/2015 22:37
    • Brief: Affimed Q2 loss per share EUR 0.19

      04/08/2015 12:30
    • Brief: Affimed Q1 loss per share EUR 0.06

      21/05/2015 12:30
    • Brief: Affimed prices public offering of common stock

      07/05/2015 03:57
    • Brief: Affimed N.V. proposes offering of common stock

      04/05/2015 21:01
    • Brief: Affimed announces Q4 results

      25/03/2015 11:41
    • Brief: Affimed completes TandAb development candidate activities

      24/03/2015 10:09
    • Brief: Affimed presents final data for AFM13 phase 1 trial

      08/12/2014 10:06
    • Brief: Affimed reports Q3 earnings per share EUR 2.17

      18/11/2014 12:39
    Previous1234Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.